Cover Image

Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials

Fuente: arXiv

Saved in:

Bibliographic Details
Main Authors:	Maity, Arnab Kumar, Garg, Jhanvi, Basu, Cynthia
Format:	Preprint
Published:	2024
Subjects:	Methodology Applications
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A Bayesian Discrete Framework for Enhancing Decision-Making Processes in Clinical Trial Designs and Evaluations
by: Pramanik, Paramahansa, et al.
Published: (2026)

Study Duration Prediction for Clinical Trials with Time-to-Event Endpoints Using Mixture Distributions Accounting for Heterogeneous Population
by: Zhang, Hong, et al.
Published: (2023)

Cumulative Logit Ordinal Regression with Proportional Odds under Nonignorable Missing Response -- Application to Phase III Trial
by: Maity, Arnab Kumar, et al.
Published: (2025)

Bayes Factor of Zero Inflated Models under Jeffereys Prior
by: Pramanik, Paramahansa, et al.
Published: (2024)

Toward Valid Generative Clinical Trial Data with Survival Endpoints
by: Chassat, Perrine, et al.
Published: (2025)

Bias in Meta-Analytic Modeling of Surrogate Endpoints in Cancer Screening Trials
by: Long, James P., et al.
Published: (2025)

Designing Efficient Hybrid and Single-Arm Trials: External Control Borrowing and Sample Size Calculation
by: Gao, Yujing, et al.
Published: (2025)

Power and Sample Size Calculations for Bayes Factors in two-arm clinical Phase II Trials with binary Endpoints
by: Kelter, Riko
Published: (2026)

Optimal sequential two-stage Bayes Factor Design for two-arm clinical Phase II Trials with binary Endpoints
by: Kelter, Riko
Published: (2026)

Semiparametric Piecewise Accelerated Failure Time Model for the Analysis of Immune-Oncology Clinical Trials
by: Sunami, Hisato, et al.
Published: (2024)

Dynamic Prediction of the Target Survival Time in Metastatic Solid Tumor Cancer Clinical Trials
by: Wang, Sidi, et al.
Published: (2026)

Fragility Measures For Typical Cases
by: Alexander, Robin, et al.
Published: (2022)

Index Date Imputation For Survival Outcomes for Externally Controlled Trials
by: Coent, Q. Le, et al.
Published: (2025)

Evaluation of Surrogate Endpoints Based on Meta-Analysis with Surrogate Indices
by: Stijven, Florian, et al.
Published: (2025)

A geometric approach in non-parametric Changepoint detection in circular data
by: Biswas, Surojit, et al.
Published: (2024)

On the Calibration of Bayesian Success Criteria and Operating Characteristics for Clinical Trials
by: Yang, Peng, et al.
Published: (2026)

[Invited Discussion] Randomization Tests to Address Disruptions in Clinical Trials: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions
by: Phillips, Rachael V., et al.
Published: (2024)

A Semiparametric Quantile Single-Index Model for Zero-Inflated Outcomes
by: Wang, Zirui, et al.
Published: (2025)

Heterogeneous Clinical Trial Outcomes via Multi-Output Gaussian Processes
by: Thomas, Owen, et al.
Published: (2024)

E-values for Adaptive Clinical Trials: Anytime-Valid Monitoring in Practice
by: Sokolova, Alexandra, et al.
Published: (2026)

Correcting for Missing Data When Evaluating Surrogate Markers in a Clinical Trial
by: Lotspeich, Sarah C., et al.
Published: (2026)

Tutorial for Surrogate Endpoint Validation Using Joint modeling and Mediation Analysis
by: Coent, Quentin Le, et al.
Published: (2025)

Multi-Dimensional Composite Endpoint Analysis via the Choquet Integral: Block Recurrent Encoding and Comparative Advantage Mapping
by: Tanboga, Ibrahim Halil
Published: (2026)

A Workflow for Evaluating Regional Treatment Effect Heterogeneity in Multi-Regional Clinical Trials
by: Zhang, Cong, et al.
Published: (2026)

A Bayesian Treatment Selection Design for Phase II Randomised Cancer Clinical Trials
by: Komaki, Moka, et al.
Published: (2025)

Age-Specific Logistic Regression with Complex Event Time Data
by: Haoxuan, et al.
Published: (2026)

A Utility Score Framework for Dose Optimization Studies with Binary Efficacy-Safety Endpoints: Sample Size Determination and Bias Characterization
by: Gu, Xuemin, et al.
Published: (2026)

Priors from Envisioned Posterior Judgments: A Novel Elicitation Approach With Application to Bayesian Clinical Trials
by: Ouyang, Yongdong, et al.
Published: (2024)

SIMBA -- A Bayesian Decision Framework for the Identification of Optimal Biomarker Subgroups for Cancer Basket Clinical Trials
by: Yuan, Shijie, et al.
Published: (2025)

BMW: Bayesian Model-Assisted Adaptive Phase II Clinical Trial Design for Win Ratio Statistic
by: Zhu, Di, et al.
Published: (2026)

Time-to-Event Estimation with Unreliably Reported Events in Medicare Health Plan Payment
by: Enache, Oana M., et al.
Published: (2026)

Predicting Distributions of Physical Activity Profiles in the NHANES Database Using a Partially Linear Fréchet Single Index Model
by: Matabuena, Marcos, et al.
Published: (2023)

Estimation and Inference for Win Measures with Multiple Ordinal Endpoints Subject to Missingness
by: Liu, Yi, et al.
Published: (2026)

Statistical Inference for Heterogeneous Treatment Effect with Right-censored Data from Synthesizing Randomized Clinical Trials and Real-world Data
by: Mao, Guangcai, et al.
Published: (2025)

Improving the Balance of Unobserved Covariates From Information Theory in Multi-Arm Randomization with Unequal Allocation Ratio
by: Ma, Xingjian, et al.
Published: (2023)

Robust Bayesian causal estimation for causal inference in medical diagnosis
by: Basu, Tathagata, et al.
Published: (2024)

Robust inference for linear regression models with possibly skewed error distribution
by: Nandy, Amarnath, et al.
Published: (2024)

Analysis of Pleiotropy for Testosterone and Lipid Profiles in Males and Females
by: Chattopadhyay, Srijan, et al.
Published: (2023)

A Joint Model of Longitudinal CVD Risk Factors, Medication Use, and Time-to-Terminal Events
by: Aghabazaz, Zeynab, et al.
Published: (2025)

Dynamic Risk-Adjusted Monitoring of Time Between Events: Applications of NHPP in Pipeline Accident Surveillance
by: Ahmad, Hussam, et al.
Published: (2025)